Manufacturing and Production

Showing 15 posts of 5863 posts found.

Optimer Pharmaceuticals appoints chief operating officer

May 14, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Biopharma firm Optimer Pharmaceuticals has announced the appointment of Eric Sirota as chief operating officer.  “Eric has tremendous experience and …
Ranbaxy image

Ranbaxy unit fined $500m for selling adulterated drugs

May 14, 2013 Manufacturing and Production FDA, GMP, Ranbaxy, fine, generics

Ranbaxy’s US subsidiary has agreed to pay fines and penalties totalling $500 million after pleading guilty to charges of manufacturing …

John LaMattina: India’s solution to drug costs

May 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …

New Board member for Misonix

May 13, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Misonix

Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.The addition of Vizirgianakis …
stan_musial

Egalet appoints Stan Musial as CFO

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Egalet, musial

Speciality pharma firm Egalet has announced the appointment of Stan Musial as chief financial officer.  Bob Radie, president and chief …
danai_brooks

Dyadic International hires chief operating officer

May 10, 2013 Manufacturing and Production, Research and Development, Sales and Marketing dyadic

Biotech firm Dyadic International has appointed Danai Brooks to the role of executive VP and chief operating officer.  Starting in …

New Viagra site launched

May 10, 2013 Manufacturing and Production, Medical Communications, Sales and Marketing ED, Pfizer, viagra

Pfizer has launched a new sales website for Viagra, the ‘little blue pill’ which is its most counterfeited medicine, to …
Aesica image

Aesica forges alliance with UK university on API synthesis

May 8, 2013 Manufacturing and Production Aesica

UK contract manufacturing organisation (CMO) Aesica has teamed up with the University of Nottingham to develop new ways to form …

Manufacturing facility news in brief

May 8, 2013 Manufacturing and Production Expeditors, Novo Nordisk, Penn Pharma, Sagent Pharma, Vertellus

A round-up of new facility developments in the pharma sector, including updates from Novo Nordisk, Sagent, Penn Pharma, Vertellus and …
J&J, image

Asian regulators take issue with J&J facilities

May 7, 2013 Manufacturing and Production India, J&J, JJ, Korea, inspection

Johnson & Johnson’s manufacturing network is under yet more scrutiny following regulatory actions by authorities in India and South Korea. …
Buffet image

Lessons from the business gurus

May 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus

Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …
Teva image

Teva says US facility will close in cost-cutting drive

May 3, 2013 Manufacturing and Production Teva, closure, cuts

Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …
28569_guenter_100

Sanofi appoints two executive members

May 3, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …
FDA image

FDA seeks manufacturing data for GSK’s trametinib

May 2, 2013 Manufacturing and Production FDA, GSK, melanoma

GlaxoSmithKline’s melanoma drug candidate trametinib has been delayed in the US by an FDA request for more information on its …
Gilead image

Manufacturing issues block Gilead approvals

May 1, 2013 Manufacturing and Production FDA, Gilead

The FDA has blocked approval of two of Gilead Sciences’ HIV drugs because of deficiencies in their marketing applications related …
The Gateway to Local Adoption Series

Latest content